Lead on Purpose

SEPTEMBER 8, 2009

Weatherhead is the author of The Power Of Adversity and chairman and CEO of Weatherchem, a private manufacturer of plastic closures for food, spice, pharmaceutical and nutraceutical products. Filed under: Integrity , Leadership , Purpose , Team Building , Trust Tagged: | Albert J.

Committee 140

Committee Automotive Ethics Productivity 140

Harvard Business Review

MARCH 24, 2017

The onus for ethical behavior falls first to the employee. Most companies talk a good ethics game and even make their goals public. Ethical behavior has to be led by example, and promoting people who ignore ethics when expedient for them tells everyone that the company wants results and it does not really care how they are obtained.

Ethics 8

Ethics Company Incentives Policies 8

Marshall Goldsmith

FEBRUARY 8, 2018

Jim Kim (President of the World Bank), Peter Drucker (founder of modern management), Paul Hersey (noted author, teacher, and personal mentor of mine), and Warren Bennis (one of the world’s greatest leadership thinkers of his time). Has been recognized as the World’s #1 Leadership Thinker. Author of two best-selling leadership books.

Executive Coaching 70

Executive Coaching CEO Magazine Banking 70

Terry Starbucker

SEPTEMBER 30, 2010

No, not the pharmaceutical kind. This pill is invisible, and sits on our bed stands every morning, waiting for us to pop it into our brain. Tweet This Post Tagged as: happiness Leave a Comment { 1 trackback } TLW 016: Ethics? What ethics? I forgot to take my happy pills. And oh yes, please, repeat as necessary.

Pharmaceuticals 243

Pharmaceuticals Ethics Self-aware Blog 243

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. Experimentation is vital.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 15, 2014

As Linda Hill and her colleagues have described, the company needed expert knowledge as it navigated the technically and ethically challenging waters of pharmaceutical development and marketing. Informal leadership Managing people' In 2008, Pfizer was struggling with an unwieldy and costly model of obtaining outside legal help.

Gilbert 9

Gilbert Participative Cooper Network Economy 9

Harvard Business Review

SEPTEMBER 19, 2016

Imagine, for example, that you’re a pharmaceutical CEO deciding whether to recall a new drug. In these cases, running the numbers and grasping what they tell you is important, but it isn’t enough. With gray area problems, you have to look hard at the economics and look past the economics. How should you make this decision?

ROI 8

ROI Long-term Conflict of Interest Pharmaceuticals 8

Harvard Business Review

JANUARY 10, 2013

initiative — prohibitions against off-label marketing under the False Claims Act — swept through the pharmaceutical industry. The most notable was Fannie Mae's $10.8 billion restatement. In another instance, a new enforcement. The largest payments were from Pfizer ($2.3 billion) and GlaxoSmithKline ($3 billion).

Finance 8

Finance Banking Press Release Pharmaceuticals 8